EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Influence of Pre‐Vaccination HPV Status on Vaccine Effectiveness Among Chinese Women: A Multicenter Cross‐Sectional Study

Lucia Li iD, Haiyue Wu, Yibo Chen, Zhanjun Shen, Kun Fu, Minghui Qiu, Yingzhen Liu, Yufei Shen, Yingnan Lu, Xinxin Wen, Siyu Yang, Kehan Zou und 7 weitere

Cancer Reports · 2025

DOI: 10.1002/cnr2.70294 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cancer Reports, 2025. Verfasst von Lucia Li und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Xiangya Hospital, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Papillomavirus Infections, Papillomavirus Vaccines, Vaccine Efficacy, Uterine Cervical Neoplasms. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Human papillomavirus (HPV) vaccines have been available in China for only 8 years, and routine HPV testing is not recommended prior to vaccination. Therefore, evaluation of HPV vaccine effectiveness and the impact of pre‐vaccination HPV infection status on vaccine protective effect in Chinese women is warranted.

Methods

From June 2022 to June 2023, women aged 18 to 50 years without a history of cervical or uterine excision were recruited from three medical institutions. Baseline characteristics were compared between vaccinated and unvaccinated participants, with inverse probability treatment weighting (IPTW) applied to adjust for confounding factors. HPV infection rates and vaccine effectiveness (VE) were calculated. Additionally, a sub‐group analysis was conducted among vaccinated women to explore the impact of pre‐vaccination HPV infection status.

Results

After adjusting for group differences, the vaccine effectiveness against new HPV16/18 infections was 76.1% (95% CI: 58.7%–86.2%) among 2285 participants. Older age and possession of a master's degree or higher were identified as protective factors, whereas increased parity and exclusive use of oral contraceptives were determined to be risk factors for HPV16/18 infection. Women with unknown pre‐vaccination HPV status exhibited significantly higher post‐vaccination rates of high‐risk HPV infections (RR 4.278, 95% CI: 2.537–7.215) compared to those who were HPV‐negative prior to vaccination. However, no significant difference in new high‐risk HPV infection rates was observed between pre‐vaccination HPV‐negative and HPV‐positive women.

Conclusion

In addition to HPV vaccination, factors such as age, parity, exclusive use of oral contraceptives, and higher education attainment were independently associated with HPV16/18 infection rates. Pre‐vaccination HPV infection status did not significantly influence the protective efficacy of the HPV vaccine against previously unencountered HPV types.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsPapillomavirus VaccinesVaccine EfficacyUterine Cervical NeoplasmsHumansFemaleAdultCross-Sectional StudiesChinaMiddle AgedYoung AdultAdolescentVaccinationHuman papillomavirus 16Human papillomavirus 18Risk FactorsEast Asian People

Stichwörter der Autor:innen

Chinese womenhuman papillomavirusprotective effectvaccines

Substanzen

Papillomavirus Vaccines

Autor:innen und Institutionen

  • Department of Gynecology, Xiangya Hospital, Central South University, Changsha, China.
  • Gynecological Oncology Research and Engineering Center of Hunan Province, Changsha, China.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
  • Department of Obstetrics & Gynecology, Changsha Hospital for Maternal & Child Health Care, Affiliated to Hunan Normal University, Changsha, China.
  • Department of Gynecology, Liling Maternal and Child Health Care Hospital, Zhuzhou, Hunan, China.
  • Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.

ORCID-Profile: Lucia Li, Yu Zhang

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Li, L., Wu, H., Chen, Y., Shen, Z., Fu, K., Qiu, M., Liu, Y., Shen, Y., Lu, Y., Wen, X., Yang, S., Zou, K., Zhang, H., Gesang, Y., Huang, H., Zhao, C., Sun, P., Wu, L., & Zhang, Y. (2025). Influence of Pre‐Vaccination HPV Status on Vaccine Effectiveness Among Chinese Women: A Multicenter Cross‐Sectional Study. Cancer Reports. https://doi.org/10.1002/cnr2.70294

Vancouver

Li L, Wu H, Chen Y, Shen Z, Fu K, Qiu M, et al. Influence of Pre‐Vaccination HPV Status on Vaccine Effectiveness Among Chinese Women: A Multicenter Cross‐Sectional Study. Cancer Reports. 2025. doi:10.1002/cnr2.70294

BibTeX
@article{Li2025,
  author = {Li, Lucia and Wu, Haiyue and Chen, Yibo and Shen, Zhanjun and Fu, Kun and Qiu, Minghui and Liu, Yingzhen and Shen, Yufei and Lu, Yingnan and Wen, Xinxin and Yang, Siyu and Zou, Kehan and Zhang, Hui and Gesang, Yangzong and Huang, Haojie and Zhao, Chao and Sun, Pengming and Wu, Lisha and Zhang, Yu},
  title = {Influence of Pre‐Vaccination HPV Status on Vaccine Effectiveness Among Chinese Women: A Multicenter Cross‐Sectional Study},
  journal = {Cancer Reports},
  year = {2025},
  doi = {10.1002/cnr2.70294}
}
Kostenlos starten →